Skip to main content

Table 3 Expression of three selected miRNA among different AML subgroup

From: Selection of three miRNA signatures with prognostic value in non-M3 acute myeloid leukemia

  miR-181a-2 P * miR-25 P * miR-362 P *
Risk category a
 Favorable 11.58 ± 0.71 0.046 15.08 ± 0.55 0.004 3.32 ± 1.22 0.001
 Intermediate 10.78 ± 1.54 14.55 ± 0.66 4.36 ± 1.09
 Poor 11.15 ± 0.98 14.59 ± 0.54 4.29 ± 0.96
FAB morphologyb
M0 Undifferentiated 11.94 ± 0.73 < 0.001 14.95 ± 0.41 0.079 3.88 ± 1.11 < 0.001
 M1 11.12 ± 1.32 14.61 ± 0.61 3.88 ± 1.15
 M2 11.34 ± 1.13 14.77 ± 0.60 3.52 ± 1.07
 M4 10.66 ± 1.17 14.54 ± 0.65 4.73 ± 1.02
 M5 9.70 ± 1.99 14.27 ± 0.70 5.02 ± 0.77
 M6 11.57 ± 1.07 14.67 ± 1.18 5.25 ± 0.04
 M7 10.93 ± 1.09 14.57 ± 1.00 4.53 ± 0.35
  1. aRisk information of two cases were missing in the TCGA data
  2. bFAB morphology information of one living patient was missing